The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure
Abstract
CONTEXT: Chronic kidney disease (CKD) is common. Kidney disease severity can be classified by estimated glomerular filtration rate (GFR) and albuminuria, but more accurate information regarding risk for progression to kidney failure is required for clinical decisions about testing, treatment, and referral. OBJECTIVE: To develop and validate predictive models for progression of CKD. DESIGN, SETTING, AND PARTICIPANTS: Development and validation of prediction models using demographic, clinical, and laboratory data from 2 independent Canadian cohorts of patients with CKD stages 3 to 5 (estimated GFR, 10-59 mL/min/1.73 m(2)) who were referred to nephrologists between April 1, 2001, and December 31, 2008. Models were developed using Cox proportional hazards regression methods and evaluated using C statistics and integrated discrimination improvement for discrimination, calibration plots and Akaike Information Criterion for goodness of fit, and net reclassification improvement (NRI) at 1, 3, and 5 years. MAIN OUTCOME MEASURE: Kidney failure, defined as need for dialysis or preemptive kidney transplantation. RESULTS: The development and validation cohorts included 3449 patients (386 with kidney failure [11%]) and 4942 patients (1177 with kidney failure [24%]), respectively. The most accurate model included age, sex, estimated GFR, albuminuria, serum calcium, serum phosphate, serum bicarbonate, and serum albumin (C statistic, 0.917; 95% confidence interval [CI], 0.901-0.933 in the development cohort and 0.841; 95% CI, 0.825-0.857 in the validation cohort). In the validation cohort, this model was more accurate than a simpler model that included age, sex, estimated GFR, and albuminuria (integrated discrimination improvement, 3.2%; 95% CI, 2.4%-4.2%; calibration [Nam and D'Agostino χ(2) statistic, 19 vs 32]; and reclassification for CKD stage 3 [NRI, 8.0%; 95% CI, 2.1%-13.9%] and for CKD stage 4 [NRI, 4.1%; 95% CI, -0.5% to 8.8%]). CONCLUSION: A model using routinely obtained laboratory tests can accurately predict progression to kidney failure in patients with CKD stages 3 to 5.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures
Steyerberg, E. W., Vickers, A. J., Cook, N. R., Gerds, T., Gonen, M., Obuchowski, N., Pencina, M. J., & Kattan, M. W. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181c30fb2 · Cited by 5,170
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., & Eknoyan, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-2-200307150-00013 · Cited by 4,615
Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating
Steyerberg, E. W. (2019) · Statistics for Biology and Health · doi:10.1007/978-3-030-16399-0 · Cited by 3,281
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,535
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Pencina, M. J., D'Agostino, R. B., & Steyerberg, E. W. (2011) · Statistics in Medicine · doi:10.1002/sim.4085 · Cited by 2,453
Tutorial in biostatistics: competing risks and multi‐state models
Putter, H., Fiocco, M., & Geskus, R. B. (2007) · Statistics in Medicine · doi:10.1002/sim.2712 · Cited by 2,440
Cited by
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Self-citationMoons, K. G. M., Altman, D. G., Reitsma, J. B., Ioannidis, J. P. A., Macaskill, P., Steyerberg, E. W., Vickers, A. J., Ransohoff, D. F., & Collins, G. S. (2015) · Annals of Internal Medicine · doi:10.7326/m14-0698 · Cited by 5,147
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
Lok, C. E., Huber, T. S., Lee, T., Shenoy, S., Yevzlin, A. S., Abreo, K., Allon, M., Asif, A., Astor, B. C., Glickman, M. H., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.12.001 · Cited by 2,590
Levey, A. S., & Coresh, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60178-5 · Cited by 1,841
Chronic Kidney Disease Diagnosis and Management: A Review
Chen, T. K., Knicely, D. H., & Grams, M. E. (2019) · JAMA · doi:10.1001/jama.2019.14745 · Cited by 1,811
Huang, Y.-Q., Liang, C.-H., He, L., Tian, J., Liang, C.-S., Chen, X., Ma, Z.-L., & Liu, Z.-Y. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.9128 · Cited by 1,765
Kalantar-Zadeh, K., Jafar, T. H., Nitsch, D., Neuen, B. L., & Perkovic, V. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00519-5 · Cited by 1,461
KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update
Daugirdas, J. T., Depner, T. A., Inrig, J., Mehrotra, R., Rocco, M. V., Suri, R. S., Weiner, D. E., Greer, N., Ishani, A., MacDonald, R., et al. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.07.015 · Cited by 1,320
Matsushita, K., Mahmoodi, B. K., Woodward, M., Emberson, J. R., Jafar, T. H., Jee, S. H., Polkinghorne, K. R., Shankar, A., Smith, D. H., Tonelli, M., et al. (2012) · JAMA · doi:10.1001/jama.2012.3954 · Cited by 988
Using recurrent neural network models for early detection of heart failure onset
Choi, E., Schuetz, A., Stewart, W. F., & Sun, J. (2017) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocw112 · Cited by 928
Selby, N. M., & Taal, M. W. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14007 · Cited by 764
Tangri, N., Grams, M. E., Levey, A. S., Coresh, J., Appel, L. J., Astor, B. C., Chodick, G., Collins, A. J., Djurdjev, O., Elley, C. R., et al. (2016) · JAMA · doi:10.1001/jama.2015.18202 · Cited by 737
Self-citationEpidemiology and risk of cardiovascular disease in populations with chronic kidney disease
Matsushita, K., Ballew, S. H., Wang, A. Y.-M., Kalyesubula, R., Schaeffner, E., & Agarwal, R. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00616-6 · Cited by 670
Age and Association of Kidney Measures With Mortality and End-stage Renal Disease
Hallan, S. I., Matsushita, K., Sang, Y., Mahmoodi, B. K., Black, C., Ishani, A., Kleefstra, N., Naimark, D., Roderick, P., Tonelli, M., et al. (2012) · JAMA · doi:10.1001/jama.2012.16817 · Cited by 636
Leening, M. J. G., Vedder, M. M., Witteman, J. C. M., Pencina, M. J., & Steyerberg, E. W. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1522 · Cited by 594
Levey, A. S., Becker, C., & Inker, L. A. (2015) · JAMA · doi:10.1001/jama.2015.0602 · Cited by 591
Shlipak, M. G., Tummalapalli, S. L., Boulware, L. E., Grams, M. E., Ix, J. H., Jha, V., Kengne, A.-P., Madero, M., Mihaylova, B., Tangri, N., et al. (2021) · Kidney International · doi:10.1016/j.kint.2020.10.012 · Cited by 581
Self-citation(2016) · PubMed · Cited by 576
Structural and Functional Changes in Human Kidneys with Healthy Aging
Hommos, M. S., Glassock, R. J., & Rule, A. D. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017040421 · Cited by 446
Defining and measuring completeness of electronic health records for secondary use
Weiskopf, N. G., Hripcsak, G., Swaminathan, S., & Weng, C. (2013) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2013.06.010 · Cited by 367
“Researchers may be interested in predicting, amongst other clinical phenomena, disease status and risk [36–38], readmission [39,40], or mortality [41,42].”
CKD: A Call for an Age-Adapted Definition
Delanaye, P., Jager, K. J., Bökenkamp, A., Christensson, A., Dubourg, L., Eriksen, B. O., Gaillard, F., Gambaro, G., van der Giet, M., Glassock, R. J., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019030238 · Cited by 357
Sumida, K., Nadkarni, G. N., Grams, M. E., Sang, Y., Ballew, S. H., Coresh, J., Matsushita, K., Surapaneni, A., Brunskill, N., Chadban, S. J., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0529 · Cited by 350
Measured and estimated glomerular filtration rate: current status and future directions
Levey, A. S., Coresh, J., Tighiouart, H., Greene, T., & Inker, L. A. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0191-y · Cited by 312
Lees, J. S., Welsh, C. E., Celis-Morales, C. A., Mackay, D., Lewsey, J., Gray, S. R., Lyall, D. M., Cleland, J. G., Gill, J. M. R., Jhund, P. S., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0627-8 · Cited by 305
Sex-Related Disparities in CKD Progression
Ricardo, A. C., Yang, W., Sha, D., Appel, L. J., Chen, J., Krousel-Wood, M., Manoharan, A., Steigerwalt, S., Wright, J., Rahman, M., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018030296 · Cited by 291
Xiao, J., Ding, R., Xu, X., Guan, H., Feng, X., Sun, T., Zhu, S., & Ye, Z. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1860-0 · Cited by 286
Ma, F., Sun, T., Liu, L., & Jing, H. (2020) · Future Generation Computer Systems · doi:10.1016/j.future.2020.04.036 · Cited by 276
The next generation of therapeutics for chronic kidney disease
Breyer, M. D., & Susztak, K. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.67 · Cited by 272
Early chronic kidney disease: diagnosis, management and models of care
Wouters, O. J., O'Donoghue, D. J., Ritchie, J., Kanavos, P. G., & Narva, A. S. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.85 · Cited by 258
Collins, G. S., Omar, O., Shanyinde, M., & Yu, L.-M. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.06.020 · Cited by 192
A Path for Translation of Machine Learning Products into Healthcare Delivery
(2020) · EMJ Innovations · doi:10.33590/emjinnov/19-00172 · Cited by 172
Emerging technologies and analytics for a new era of value-centered marketing in healthcare
Agarwal, R., Dugas, M., Gao, G. (., & Kannan, P. K. (2020) · Journal of the Academy of Marketing Science · doi:10.1007/s11747-019-00692-4 · Cited by 175
“Predictive analytics have successfully leveraged EHR data to better understand who is at risk of developing various health conditions (Tangri 2011), incurring high costs (Bates et al. 2014), and benefiting from specific treatments (Jiang et al. 2018).”
BackgroundSingh, A., Nadkarni, G., Gottesman, O., Ellis, S. B., Bottinger, E. P., & Guttag, J. V. (2015) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2014.11.005 · Cited by 136
Cichosz, S. L., Johansen, M. D., & Hejlesen, O. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815611680 · Cited by 101
George, C., Echouffo-Tcheugui, J. B., Jaar, B. G., Okpechi, I. G., & Kengne, A. P. (2022) · BMC Medicine · doi:10.1186/s12916-022-02438-6 · Cited by 91
Huang, J., Huth, C., Covic, M., Troll, M., Adam, J., Zukunft, S., Prehn, C., Wang, L., Nano, J., Scheerer, M. F., et al. (2020) · Diabetes · doi:10.2337/db20-0586 · Cited by 60
Effect of large weight reductions on measured and estimated kidney function
von Scholten, B. J., Persson, F., Svane, M. S., Hansen, T. W., Madsbad, S., & Rossing, P. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0474-0 · Cited by 52
Barriers to Achieving Economies of Scale in Analysis of EHR Data: A Cautionary Tale
Sendak, M. P., Balu, S., & Schulman, K. A. (2017) · Applied Clinical Informatics · doi:10.4338/aci-2017-03-cr-0046 · Cited by 45
Serum tryptase concentration and progression to end‐stage renal disease
Jesky, M. D., Stringer, S. J., Fenton, A., Ng, K. P., Yadav, P., Ndumbo, M., McCann, K., Plant, T., Dasgupta, I., Harding, S. J., et al. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12622 · Cited by 26
Effect of weight reductions on estimated kidney function: Post-hoc analysis of two randomized trials
von Scholten, B. J., Davies, M. J., Persson, F., Hansen, T. W., Madsbad, S., Endahl, L., Jepsen, C. H., & Rossing, P. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.04.003 · Cited by 11
Expectation of clinical decision support systems: a survey study among nephrologist end-users
Kotsis, F., Bächle, H., Altenbuchinger, M., Dönitz, J., Njipouombe Nsangou, Y. A., Meiselbach, H., Kosch, R., Salloch, S., Bratan, T., Zacharias, H. U., et al. (2023) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-023-02317-x · Cited by 11
Metadata
- Authors
- Tangri, N.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2011-04-20
- Volume
- 305
- Issue
- 15
- Pages
- 1553
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2165817472
- Cited by
- 1,348
- References
- 44
- FWCI
- 39.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.